Royal London improves diabetes underwriting

Published  24 April 2023
   1 min read

Royal London has introduced a number of changes to its diabetes underwriting philosophy.

The changes are in line with the mutual insurer’s commitment to regularly enhance the most common areas of its protection underwriting disclosure. The changes will improve outcomes for customers living with type 1 diabetes and ensure type 2 diabetes loadings are appropriate.

It has also removed or reduced some of the additional loadings applied in underwriting diabetes. For example, the loading applied for the complication of background retinopathy has been reduced. In addition, it has introduced a bespoke approach for pre-diabetes allowing more customers to get a decision at the point of application.

Craig Paterson, Chief Underwriter at Royal London, said:

"The improvements to our underwriting of customers living with diabetes continues our theme of focussing on evidence-based underwriting and boosting access to protection insurance. The changes reaffirm our commitment to regularly review and enhance our offering, ensuring our customer journey is quick and efficient, and allows more people to protect themselves and their families."

For further information please contact:

Neil Cameron, PR Manager

About Royal London

Royal London is the largest mutual life, pensions and investment company in the UK, and in the top 25 mutuals globally, with assets under management of £162 billion, 8.6 million policies in force and over 4,200 employees. Figures quoted are as at 31 December 2023. Learn more at royallondon.com.